CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-22 | ALEXANDER SUSAN H EVP Chief Legal Corp Svc & Sec | Option exercise | +1,635 | 25,095 | ||
| 2018-02-22 | ALEXANDER SUSAN H EVP Chief Legal Corp Svc & Sec | Shares withheld for taxes | −727 | $284.81 | $207K | 24,368 |
| 2018-02-22 | ALEXANDER SUSAN H EVP Chief Legal Corp Svc & Sec | Option exercise · Restricted Stock Unit | −1,635 | 3,325 | ||
| 2018-02-22 | ALEXANDER SUSAN H EVP Chief Legal Corp Svc & Sec | Other disposition · Restricted Stock Unit | −843 | 2,482 | ||
| 2018-02-20 | Sandrock Alfred EVP, Chief Medical Officer | Sale | −743 | $292.00 | $217K | 6,553.38 |
| 2018-02-15 | Sandrock Alfred EVP, Chief Medical Officer | Sale | −1,294 | $298.85 | $387K | 7,296.38 |
| 2018-02-15 | Vounatsos Michel Chief Executive Officer | Option exercise | +5,354 | 10,233.46 | ||
| 2018-02-15 | Vounatsos Michel Chief Executive Officer | Shares withheld for taxes | −1,877 | $299.38 | $562K | 8,356.46 |
| 2018-02-15 | Vounatsos Michel Chief Executive Officer | Option exercise · Restricted Stock Unit | −5,354 | 20,146 | ||
| 2018-02-15 | Vounatsos Michel Chief Executive Officer | Other disposition · Restricted Stock Unit | −3,144 | 17,002 | ||
| 2018-02-15 | Sandrock Alfred EVP, Chief Medical Officer | Option exercise | +1,339 | 9,186.38 | ||
| 2018-02-15 | Sandrock Alfred EVP, Chief Medical Officer | Shares withheld for taxes | −596 | $299.38 | $178K | 8,590.38 |
| 2018-02-15 | Sandrock Alfred EVP, Chief Medical Officer | Option exercise · Restricted Stock Unit | −1,339 | 5,041 | ||
| 2018-02-15 | Sandrock Alfred EVP, Chief Medical Officer | Other disposition · Restricted Stock Unit | −787 | 4,254 | ||
| 2018-02-15 | McKenzie Paul EVP Pharmaceutical Oper & Tech | Option exercise | +1,472 | 4,853.82 | ||
| 2018-02-15 | McKenzie Paul EVP Pharmaceutical Oper & Tech | Shares withheld for taxes | −442 | $299.38 | $132K | 4,411.82 |
| 2018-02-15 | McKenzie Paul EVP Pharmaceutical Oper & Tech | Option exercise · Restricted Stock Unit | −1,472 | 5,538 | ||
| 2018-02-15 | McKenzie Paul EVP Pharmaceutical Oper & Tech | Other disposition · Restricted Stock Unit | −864 | 4,674 | ||
| 2018-02-15 | Ehlers Michael D EVP, Research and Development | Option exercise | +1,712 | 5,407.36 | ||
| 2018-02-15 | Ehlers Michael D EVP, Research and Development | Shares withheld for taxes | −509 | $299.38 | $152K | 4,898.36 |
Page 58 of 61 · 1,204 trades